J
Jerome Nicol
Researcher at University of Paris
Publications - 3
Citations - 130
Jerome Nicol is an academic researcher from University of Paris. The author has contributed to research in topics: Seroprevalence & Cumulative incidence. The author has an hindex of 3, co-authored 3 publications receiving 75 citations.
Papers
More filters
Posted ContentDOI
Seroprevalence of SARS-CoV-2 among adults in three regions of France following the lockdown and associated risk factors: a multicohort study.
Fabrice Carrat,Xavier de Lamballerie,Delphine Rahib,Hélène Blanché,Nathanael Lapidus,Fanny Artaud,Sofiane Kab,Adeline Renuy,Fabien Szabo de Edelenyi,Laurence Meyer,Nathalie Lydié,Marie-Aline Charles,Pierre-Yves Ancel,Florence Jusot,Alexandra Rouquette,Stéphane Priet,Paola M Saba Villaroel,Toscane Fourié,Clovis Lusivika-Nzinga,Jerome Nicol,Stephane Legot,Nathalie Druesne-Pecollo,Younes Essedik,Cindy Lai,Jean-Marie Gagliolo,Jean-François Deleuze,Nathalie Bajos,Gianluca Severi,Mathilde Touvier,Marie Zins +29 more
TL;DR: At the end of the lockdown the prevalence of anti-SARS-CoV-2 IgG or neutralizing antibodies remained low in the French adult population, even in regions with high reported rates of COVID-19.
Journal ArticleDOI
Corrigendum to: Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study.
Fabrice Carrat,Xavier de Lamballerie,Delphine Rahib,Hélène Blanché,Nathanael Lapidus,Fanny Artaud,Sofiane Kab,Sofiane Kab,Adeline Renuy,Adeline Renuy,Fabien Szabo de Edelenyi,Laurence Meyer,Nathalie Lydié,Marie-Aline Charles,Pierre-Yves Ancel,Pierre-Yves Ancel,Florence Jusot,Alexandra Rouquette,Stéphane Priet,Paola Mariela Saba Villarroel,Toscane Fourié,Clovis Lusivika-Nzinga,Jerome Nicol,Stephane Legot,Stephane Legot,Nathalie Druesne-Pecollo,Younes Esseddik,Cindy Lai,Jean-Marie Gagliolo,Jean-François Deleuze,Nathalie Bajos,Gianluca Severi,Gianluca Severi,Mathilde Touvier,Marie Zins,Marie Zins +35 more
TL;DR: In this paper, the authors aimed to estimate the seropositivity to anti-SARS-CoV-2 antibodies in May-June 2020 after the first lockdown period in adults living in three regions in France and identify the associated risk factors.
Journal ArticleDOI
Seroprevalence of SARS-CoV-2 Among Adults in Three Regions of France Following the Lockdown and Associated Risk Factors: A Multicohort Study
Fabrice Carrat,Xavier de Lamballerie,Delphine Rahib,Hélène Blanché,Nathanael Lapidus,Fanny Artaud,Sofiane Kab,Adeline Renuy,Fabien Szabo de Edelenyi,Laurence Meyer,Nathalie Lydié,Marie-Aline Charles,Pierre-Yves Ancel,Florence Jusot,Alexandra Rouquette,Stéphane Priet,Paola Mariela Saba Villarroel,Toscane Fourié,Clovis Lusivika-Nzinga,Jerome Nicol,Stephane Legot,Nathalie Druesne-Pecollo,Younes Esseddik,Cindy Lai,Jean-Marie Gagliolo,Jean-François Deleuze,Nathalie Bajos,Gianluca Severi,Mathilde Touvier,Marie Zins,Sapris Groups,Sapris-Sero Study +31 more
TL;DR: At the end of the lockdown the prevalence of anti-SARS-CoV-2 IgG or neutralizing antibodies remained low in the French adult population, even in regions with high reported rates of COVID-19.